Kisely, S., Dangelo-Kemp, D., Taylor, M., Liu, D., Graham, S., Hartmann, J., & Colman, S. (2022). The impact of COVID-19 on antipsychotic prescriptions for patients with schizophrenia in Australia. Australian & New Zealand Journal of Psychiatry, 56(6), 642. https://doi.org/10.1177/00048674211025716
Chicago Style (17th ed.) CitationKisely, Steve, Dante Dangelo-Kemp, Mark Taylor, Dennis Liu, Simon Graham, Jodie Hartmann, and Sam Colman. "The Impact of COVID-19 on Antipsychotic Prescriptions for Patients with Schizophrenia in Australia." Australian & New Zealand Journal of Psychiatry 56, no. 6 (2022): 642. https://doi.org/10.1177/00048674211025716.
MLA (9th ed.) CitationKisely, Steve, et al. "The Impact of COVID-19 on Antipsychotic Prescriptions for Patients with Schizophrenia in Australia." Australian & New Zealand Journal of Psychiatry, vol. 56, no. 6, 2022, p. 642, https://doi.org/10.1177/00048674211025716.